Chargement en cours...
The potential for liquid biopsies in the precision medical treatment of breast cancer
Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology. Circulating biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) may enh...
Enregistré dans:
| Publié dans: | Cancer Biol Med |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Chinese Anti-Cancer Association
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4850125/ https://ncbi.nlm.nih.gov/pubmed/27144060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.28092/j.issn.2095-3941.2016.0007 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|